Viviana Galimberti

Summary

Affiliation: European Institute of Oncology
Country: Italy

Publications

  1. pmc Management training for hospital administrators: sentinel lymph-node biopsy under local anaesthetic for carcinoma of the breast-organizational and economic impact
    V Galimberti
    European Institute of Oncology, Via G Ripamonti 435, I 20141, Milan, Italy
    Ecancermedicalscience 2:74. 2008
  2. pmc Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial
    Viviana Galimberti
    Molecular Senology Unit, Senology Division, European Institute of Oncology, Milan, Italy
    Lancet Oncol 14:297-305. 2013
  3. ncbi request reprint Can axillary and supraclavicular radiotherapy be avoided after breast-conserving surgery and axillary dissection in women with multiple involved axillary nodes? Experience at the European Institute of Oncology
    Viviana Galimberti
    Department of Senology, European Institute of Oncology, Milan, Italy
    Tumori 94:52-8. 2008
  4. ncbi request reprint Clinical experience with axillary presentation breast cancer
    Viviana Galimberti
    Department of Senology, European Institute of Oncology, Milan, Italy
    Breast Cancer Res Treat 88:43-7. 2004
  5. ncbi request reprint Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?
    Viviana Galimberti
    Division of Senology, Unit of Molecular Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Breast Cancer Res Treat 131:819-25. 2012
  6. doi request reprint Positive axillary sentinel lymph node: is axillary dissection always necessary?
    Viviana Galimberti
    Division ofSenology, European Institute of Oncology, Milan, Italy
    Breast 20:S96-8. 2011
  7. doi request reprint Is electron beam intraoperative radiotherapy (ELIOT) safe in pregnant women with early breast cancer? In vivo dosimetry to assess fetal dose
    Viviana Galimberti
    Unit of Molecular Senology, Senology Department, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Ann Surg Oncol 16:100-5. 2009
  8. ncbi request reprint Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients
    Viviana Galimberti
    Divisions of Senology, European Institute of Oncology, Milan, Italy
    Ann Surg Oncol 9:924-8. 2002
  9. ncbi request reprint Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study
    Umberto Veronesi
    Scientific Direction, European Institute of Oncology, Milan, Italy
    Lancet Oncol 7:983-90. 2006
  10. doi request reprint Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases
    Umberto Veronesi
    Scientific Director European Institute of Oncology, Via G Ripamonti 435, I 20141 Milan, Italy
    Eur J Cancer 45:1381-8. 2009

Detail Information

Publications68

  1. pmc Management training for hospital administrators: sentinel lymph-node biopsy under local anaesthetic for carcinoma of the breast-organizational and economic impact
    V Galimberti
    European Institute of Oncology, Via G Ripamonti 435, I 20141, Milan, Italy
    Ecancermedicalscience 2:74. 2008
    ..It compares the total cost of the two treatment approaches, in terms of average income and of their impact on the subsequent programming of operations and hence on waiting lists and income...
  2. pmc Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial
    Viviana Galimberti
    Molecular Senology Unit, Senology Division, European Institute of Oncology, Milan, Italy
    Lancet Oncol 14:297-305. 2013
    ..We designed IBCSG trial 23-01 to determine whether no axillary dissection was non-inferior to axillary dissection in patients with one or more micrometastatic (≤2 mm) sentinel nodes and tumour of maximum 5 cm...
  3. ncbi request reprint Can axillary and supraclavicular radiotherapy be avoided after breast-conserving surgery and axillary dissection in women with multiple involved axillary nodes? Experience at the European Institute of Oncology
    Viviana Galimberti
    Department of Senology, European Institute of Oncology, Milan, Italy
    Tumori 94:52-8. 2008
    ..We performed a retrospective analysis of patients with 4 or more axillary nodes involved and sufficient follow-up to provide indications as to whether our current treatment is adequate...
  4. ncbi request reprint Clinical experience with axillary presentation breast cancer
    Viviana Galimberti
    Department of Senology, European Institute of Oncology, Milan, Italy
    Breast Cancer Res Treat 88:43-7. 2004
    ..We present guidelines for the work-up of patients presenting with axillary disease...
  5. ncbi request reprint Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?
    Viviana Galimberti
    Division of Senology, Unit of Molecular Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Breast Cancer Res Treat 131:819-25. 2012
    ..Nevertheless, a subset of patients might be at high risk of developing overt axillary disease and efforts should be made to identify such patients by ancillary analyses of the results of ongoing or recently published clinical trials...
  6. doi request reprint Positive axillary sentinel lymph node: is axillary dissection always necessary?
    Viviana Galimberti
    Division ofSenology, European Institute of Oncology, Milan, Italy
    Breast 20:S96-8. 2011
    ..Ancillary analyses of the IBCSG 23-01 and AMAROS trials, still in follow-up, may be able to do this...
  7. doi request reprint Is electron beam intraoperative radiotherapy (ELIOT) safe in pregnant women with early breast cancer? In vivo dosimetry to assess fetal dose
    Viviana Galimberti
    Unit of Molecular Senology, Senology Department, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Ann Surg Oncol 16:100-5. 2009
    ..We conclude that studies on the use of ELIOT in pregnant women treated with conservative breast surgery are justified...
  8. ncbi request reprint Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients
    Viviana Galimberti
    Divisions of Senology, European Institute of Oncology, Milan, Italy
    Ann Surg Oncol 9:924-8. 2002
    ..Use of lymphoscintigraphy to visualize sentinel nodes reveals that IMNs often receive lymph from the area containing the tumor...
  9. ncbi request reprint Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study
    Umberto Veronesi
    Scientific Direction, European Institute of Oncology, Milan, Italy
    Lancet Oncol 7:983-90. 2006
    ..Results of our previous trial showed that SLNB accurately screens the ALN for metastasis in breast cancers of diameter 2 mm or less. We aimed to update this trial with results from longer follow-up...
  10. doi request reprint Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases
    Umberto Veronesi
    Scientific Director European Institute of Oncology, Via G Ripamonti 435, I 20141 Milan, Italy
    Eur J Cancer 45:1381-8. 2009
    ..PREMISES: Sentinel node biopsy (SNB) in patients with breast carcinoma accurately predicts the axillary node status. However, in some 4-7% of patients with negative sentinel nodes, the remaining axillary nodes harbour cancer cells...
  11. doi request reprint Local therapy for breast cancer in malignant lymphoma survivors
    Mattia Intra
    Division of Breast Surgery, European Institute of Oncology, Milan, Italy
    Breast 20:S99-103. 2011
    ..We performed a retrospective review to assess the potential of performing breast conservative surgery and intraoperative radiotherapy with electrons (ELIOT), in these patients...
  12. ncbi request reprint Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer
    Giovanni Paganelli
    Division of Nuclear Medicine, European Institute of Oncology, Milan, Italy
    Clin Cancer Res 13:5646s-5651s. 2007
    ..In a continuous effort to seek for anticancer treatments with minimal side effects, we aim at proving the feasibility of the Intraoperative Avidination for Radionuclide Therapy, a new procedure for partial breast irradiation...
  13. ncbi request reprint Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial
    Umberto Veronesi
    Scientific Directorate, European Institute of Oncology, Milan, Italy Electronic address
    Lancet Oncol 14:1269-77. 2013
    ..However, its ability to control for recurrence of local disease required confirmation in a randomised controlled trial...
  14. pmc Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases
    Umberto Veronesi
    Istituto Europeo di Oncologia, Division of Radiotherapy, Istituto Europeo di Oncologia, Milan, Italy
    Ann Surg 242:101-6. 2005
    ..The new mobile linear accelerators easily moved close to the operating table to allow the full-dose irradiation during surgery...
  15. ncbi request reprint Conservative treatment of breast cancer: its evolution
    Alberto Luini
    Division of Breast Surgery, European Institute of Oncology, Milan, Italy
    Breast Cancer Res Treat 94:195-8. 2005
    ..From an oncological perspective, outcome was found to be equally effective, and this key observation provided us with significant impetus to investigate the effects of reducing the radiotherapy field...
  16. doi request reprint Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons
    Umberto Veronesi
    European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Breast Cancer Res Treat 124:141-51. 2010
    ..4 and 89.7%. ELIOT appears a promising feature in early breast cancer treated with breast conserving surgery, reducing the exposure of normal tissues to radiations and shortening the radiation course from 6 weeks to one single session...
  17. doi request reprint Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates
    Oreste Gentilini
    Division of Breast Surgery, European Institute of Oncology, Milan, Italy
    Ann Surg Oncol 19:3771-6. 2012
    ..Mastectomy is still considered the treatment of first choice in patients with ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery (BCS) and whole-breast radiotherapy...
  18. ncbi request reprint A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer
    Umberto Veronesi
    Division of Senology, European Institute of Oncology, Milan, Italy
    N Engl J Med 349:546-53. 2003
    ..Although numerous studies have shown that the status of the sentinel node is an accurate predictor of the status of the axillary nodes in breast cancer, the efficacy and safety of sentinel-node biopsy require validation...
  19. pmc Nonpalpable breast carcinomas: long-term evaluation of 1,258 cases
    Umberto Veronesi
    IEO European Institute of Oncology, Milan, Italy
    Oncologist 15:1248-52. 2010
    ..At present in our institution some 20% of the cases are treated when nonpalpable. The aim of the present study is to analyze the characteristics and prognosis of such tumors treated in a single institution...
  20. doi request reprint Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women
    Giovanni Battista Ivaldi
    Department of Radiation Oncology, European Institute of Oncology, Milan, Italy
    Int J Radiat Oncol Biol Phys 72:485-93. 2008
    ..To report the acute and preliminary data on late toxicity of a pilot study of boost with electron intraoperative therapy followed by hypofractionated external beam radiotherapy (HEBRT) of the whole breast...
  21. doi request reprint Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer?
    Carlos A Garcia-Etienne
    Breast Surgery Department, European Institute of Oncology, Milan, Italy
    Ann Surg Oncol 16:3380-7. 2009
    ..The optimal local therapy for women with BRCA-associated breast carcinoma remains controversial. We report the outcome of BCS in BRCA mutation carriers followed at a single institution...
  22. ncbi request reprint Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology
    Simonetta Monti
    Division of Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milano, Italy
    Ann Surg Oncol 14:2928-31. 2007
    ..We report our experience using radio-guided occult lesion localization (ROLL) for locating and removing non-palpable breast lesions together with sentinel node biopsy (SNB) to assess axillary status. We call the technique SNOLL...
  23. doi request reprint Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study
    Umberto Veronesi
    European Institute of Oncology, Milan, Italy
    Ann Surg 251:595-600. 2010
    ..We present 10-year follow-up of our single-institute trial designed to compare outcomes in patients who received no axillary dissection if the sentinel node was negative, with patients who received complete axillary dissection...
  24. ncbi request reprint Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection
    Umberto Veronesi
    European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Eur J Cancer 41:231-7. 2005
    ..The 5 year overall survival rate of the whole series was 98%. Patients with negative sentinel node biopsies not submitted to axillary dissection show during follow-up a rate of overt axillary metastases that is lower than that expected...
  25. ncbi request reprint Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy
    Mattia Intra
    Division of Breast Surgery, European Institute of Oncology, Via Ripamonti, 435, 20141, Milan, Italy
    Ann Surg Oncol 12:895-9. 2005
    ..Although a previous SLNB is often considered a contraindication for a subsequent SLNB, few data support this concern...
  26. ncbi request reprint Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement
    Marco Colleoni
    Division of Medical Oncology, Department of Medicine, Istituto Europeo di Oncologia, Via Ripamonti 435, 20141, Milan, Italy
    J Clin Oncol 23:1379-89. 2005
    ....
  27. doi request reprint Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome
    Emilia Montagna
    Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy
    Clin Breast Cancer 13:31-9. 2013
    ..This study assesses outcome in terms of disease-free survival (DFS) and overall survival (OS) of special types of triple-negative breast cancer (TNBC)...
  28. doi request reprint Breast-conserving surgery in 201 very young patients (<35 years)
    Oreste Gentilini
    Division of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
    Breast 19:55-8. 2010
    ..Surgical treatment of breast cancer in very young patients (<35 years) is still a matter of debate, since age is a predictive factor of local recurrence after breast conservation...
  29. ncbi request reprint Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution
    Mattia Intra
    Division of Breast Surgery, European Institute of Oncology, Milan, Italy
    Cancer 101:905-12. 2004
    ..Synchronous bilateral invasive breast carcinoma (SBIBC) ranged in incidence from 0.3% to as high as 12%...
  30. doi request reprint Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy
    Marco Colleoni
    Department of Medicine, Research Unit in Medical Senology, European Institute of Oncology, Milan, Italy
    Breast Cancer Res Treat 116:359-69. 2009
    ..4, 95% CI 3.5-11.6, for DFS; HR 3.6 95% CI 2.4-5.6 for OS). Response and outcome after PCT are correlated with the degree of expression of steroid hormone receptors. Studies on tailored preoperative therapies are needed...
  31. ncbi request reprint The sentinel lymph node biopsy under local anesthesia in breast carcinoma: experience of the European Institute of Oncology and impact on quality of life
    Alberto Luini
    Senology Division, European Institute of Oncology, Milan, Italy
    Breast Cancer Res Treat 89:69-74. 2005
    ..We previously published our preliminary experience with 115 patients; here we present an update of our experience with particular attention devoted to quality of life...
  32. ncbi request reprint The pilot trial on intraoperative radiotherapy with electrons (ELIOT): update on the results
    Alberto Luini
    Division of Breast Surgery, University of Milan, Milan, Italy
    Breast Cancer Res Treat 93:55-9. 2005
    ..At the European Institute of Oncology we started our study on ELIOT in 1999; the first step has been a phase I-II trial to test feasibility and tolerance of ELIOT in patients candidate to breast conserving surgery...
  33. doi request reprint Sentinel lymph node biopsy in pregnant patients with breast cancer
    Oreste Gentilini
    Division of Senology, European Institute of Oncology, Milan, Italy
    Eur J Nucl Med Mol Imaging 37:78-83. 2010
    ..Sentinel lymph node biopsy (SLNB) is currently not recommended in pregnant patients with breast cancer due to radiation concerns...
  34. pmc Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy
    Giuseppe Viale
    Department of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan School of Medicine, Milan, Italy
    Ann Surg 241:319-25. 2005
    ..To assess whether the risk for nonsentinel node metastases may be predicted, thus sparing a subgroup of patients with breast carcinoma and a positive sentinel lymph node (SLN) biopsy completion axillary lymph node dissection (ALND)...
  35. doi request reprint Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institution
    Oreste Gentilini
    Division of Senology, European Institute of Oncology, Milano, Italy
    Ann Surg Oncol 18:2879-84. 2011
    ..This study was designed to present the 5-year results of patients with multicentric breast cancer who underwent sentinel lymph node biopsy (SLNB) in a single institution...
  36. doi request reprint Influence of margin status on outcomes in lobular carcinoma: experience of the European Institute of Oncology
    Viviana Galimberti
    Division of Senology, European Institute of Oncology, University of Milan, Milan, Italy
    Ann Surg 253:580-4. 2011
    ..Our aim was to evaluate the influence of margin status on outcomes with a view assessing the appropriateness of conservative surgery in this breast cancer subtype...
  37. ncbi request reprint The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology
    Alberto Luini
    Division of Breast Surgery, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Breast Cancer Res Treat 89:159-63. 2005
    ..A previous breast biopsy has been considered a relative contraindication to SLNB. We examined the accuracy of SLNB by following the axillary relapses after the procedure in patients who had undergone a breast biopsy before SLNB...
  38. ncbi request reprint Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment
    Marco Colleoni
    Department of Medicine, European Institute of Oncology, Milan, Italy
    Clin Cancer Res 10:6622-8. 2004
    ..The purpose of this research was to identify factors predicting response to preoperative chemotherapy...
  39. ncbi request reprint Ipsilateral breast tumor reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcome
    Oreste Gentilini
    Division of Breast Surgery, European Institute of Oncology, Milan, Italy
    J Surg Oncol 94:375-9. 2006
    ..To evaluate the ipsilateral breast tumor reappearance (IBTR) rate after breast conservative surgery (BCS) following primary chemotherapy (PC) and to assess whether positive margins affects IBTR rate and overall survival (OS)...
  40. ncbi request reprint Real-time in vivo dosimetry using micro-MOSFET detectors during intraoperative electron beam radiation therapy in early-stage breast cancer
    Mario Ciocca
    Department of Medical Physics, European Institute of Oncology, Milano, Italy
    Radiother Oncol 78:213-6. 2006
    ..In the present study, a further step was made, aiming at the improvement of the effectiveness of in vivo dosimetry, based on a real-time check of the dose...
  41. ncbi request reprint IART: intraoperative avidination for radionuclide treatment. A new way of partial breast irradiation
    Giovanni Paganelli
    Division of Nuclear Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Breast 16:17-26. 2007
    ..7 GBq 90Y-biotin (100mCi). A further large clinical trial facing IART in combination with reduced external-beam radiotherapy is, in our opinion, fully justified...
  42. ncbi request reprint When sentinel lymph node is intramammary
    Mattia Intra
    Breast Surgery Department, European Institute of Oncology, Via Ripamonti 435, Milan, MI 20141, Italy
    Ann Surg Oncol 15:1304-8. 2008
    ..Little attention has been placed to the presence of intramammary sentinel lymph nodes (intraMSLNs) on preoperative lymphoscintigraphy...
  43. doi request reprint Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation
    Emilia Montagna
    Division of Medical Oncology, Department of Medicine, Unit Research of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Breast Cancer Res Treat 129:867-75. 2011
    ..The outcome of OBC patients is comparable with that of matched patients with small sized breast cancer. High risk of relapse and death was observed in OBC patients with triple negative tumours and extensive nodal involvement...
  44. doi request reprint Immediate breast reconstruction after mastectomy
    Paolo Veronesi
    Department of Breast Surgery, European Institute of Oncology, Milan, Italy
    Breast 20:S104-7. 2011
    ..Aim of this review is to investigate the safety of immediate postmastectomy reconstruction for invasive cancers and in the elderly population...
  45. ncbi request reprint Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients
    Roberto Gennari
    Department of Surgery, European Institute of Oncology, Milan, Italy
    Cancer 101:1302-10. 2004
    ..The aim of the study was to evaluate the relation between biologic features at first diagnosis of breast carcinoma and treatment choice for postmenopausal women > or = 50 years to optimize treatment in the elderly...
  46. doi request reprint Invasive lobular breast cancer: subtypes and outcome
    Monica Iorfida
    Research Unit in Medical Senology, Department of Medicine, European Institute of Oncology, Milan, Italy
    Breast Cancer Res Treat 133:713-23. 2012
    ..The outcome of ILC significantly correlated with histological and immunohistochemically defined molecular subtypes. New tailored strategies should be explored in these subgroups of patients with poor outcome...
  47. doi request reprint Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin
    Giovanni Paganelli
    European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Eur J Nucl Med Mol Imaging 37:203-11. 2010
    ..Reduced duration EBRT (40 Gy) is given subsequently...
  48. ncbi request reprint Rethinking TNM: a breast cancer classification to guide to treatment and facilitate research
    Umberto Veronesi
    Scientific Director European Institute of Oncology, Milan, Italy
    Breast J 15:291-5. 2009
    ....
  49. doi request reprint Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series
    Giuseppe Viale
    European Institute of Oncology, University of Milan, Italy
    Breast Cancer Res Treat 117:211-4. 2009
    ..Classical lobular histology is not an independent factor in the prognosis of early breast cancer...
  50. ncbi request reprint Report on a case of breast sarcoma metastatic to the axillary lymph nodes
    Jack Antonio Diaz Brito
    Division of Breast Surgery, European Institute of Oncology, Milan, Italy
    Tumori 92:188-90. 2006
    ..We report a case of a 65-year-old woman affected by follicular dendritic cell sarcoma of the left breast. Six months after breast surgery she developed an axillary metastasis from the same disease...
  51. ncbi request reprint Sentinel lymph node biopsy performed with local anesthesia in patients with early-stage breast carcinoma
    Alberto Luini
    Senology Division, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Arch Surg 137:1157-60. 2002
    ..This method represents an interesting development in breast-conserving surgery...
  52. doi request reprint No more axillary dissection in patients with ductal intraepithelial neoplasia (DIN)
    Gabriel Farante
    Division of Senology, European Institute of Oncology, 20141 Milan, Italy
    Eur J Cancer 46:476-8. 2010
    ..Even if the SLNB is positive, AD should not be performed immediately but only in cases where an invasive component is found on definitive pathological examination of the DIN lesions...
  53. doi request reprint Conservative surgery in patients with multifocal/multicentric breast cancer
    Oreste Gentilini
    Division of Breast Surgery, European Institute of Oncology, Milan, Italy
    Breast Cancer Res Treat 113:577-83. 2009
    ..We retrospectively evaluate outcome of patients with MF/MC cancers who had breast conservation with specific attention on local control and predictive factors of recurrence...
  54. ncbi request reprint Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast
    Mattia Intra
    Department of Breast Surgery, European Institute of Oncology, Milan, Italy
    Arch Surg 138:309-13. 2003
    ....
  55. ncbi request reprint Investigation of 18F-FDG PET in the selection of patients with breast cancer as candidates for sentinel node biopsy after neoadjuvant therapy
    Laura Gilardi
    Division of Nuclear Medicine, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Eur J Nucl Med Mol Imaging 37:1834-41. 2010
    ....
  56. ncbi request reprint Incidence, predictive factors, and prognosis for winged scapula in breast cancer patients after axillary dissection
    Luiz Felipe Nevola Teixeira
    Physiotherapy Department, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Support Care Cancer 22:1611-7. 2014
    ..Data regarding its incidence, predictive factors, and patient prognosis remains inconsistent. Ignorance of its diagnosis may lead to undertreatment with physical morbidity...
  57. ncbi request reprint Axillary radiotherapy instead of axillary dissection: a randomized trial. Italian Oncological Senology Group
    Stefano Zurrida
    Department of Senology, European Institute of Oncology, Milan, Italy
    Ann Surg Oncol 9:156-60. 2002
    ..We evaluated disease-free and overall survival in patients with early breast cancer treated by breast-conservation surgery without dissection of axillary lymph nodes, receiving or not receiving axillary radiotherapy (RT)...
  58. doi request reprint The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy
    Gabriel Farante
    Division of Senology, European Institute of Oncology, IEO, Via Ripamonti 435, 20141 Milan, Italy
    Breast Cancer Res Treat 128:369-78. 2011
    ..A general agreement on the best management of DIN does not exist as yet. New large trials are needed in order to define the best management of DIN patients which is (in most respects) still complex and controversial...
  59. doi request reprint Second malignancies following breast cancer treatment: a case-control study based on the Peridose methodology. Allegro project (task 5.4)
    Roberto Orecchia
    Dept of Radiation Oncology, European Institute of Oncology, Via Ripamonti 435, Milan, Italy
    Tumori 98:715-21. 2012
    ..Minimum 5-year follow-up was required. Each index case was matched with 5 controls by 1) year of birth, 2) year of radiotherapy and 3) follow-up duration. Peridose-software was used to calculate peripheral dose...
  60. doi request reprint Weekly epirubicin in the treatment of gestational breast cancer (GBC)
    Fedro A Peccatori
    Department of Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Breast Cancer Res Treat 115:591-4. 2009
    ..GBC is a rare disease and chemotherapy in this setting lacks a standardized approach...
  61. ncbi request reprint Male breast cancer: a special therapeutic problem. Anything new? (Review)
    Roberto Gennari
    Department of Surgery, European Institute of Oncology, 20141 Milano, Italy
    Int J Oncol 24:663-70. 2004
    ....
  62. ncbi request reprint Video-assisted management of malignant pleural effusion in breast carcinoma
    Roberto Gasparri
    Division of Thoracic Surgery, European Institute of Oncology, Milan, Italy
    Cancer 106:271-6. 2006
    ..The results of video-thoracoscopic approach (VATS) chemical pleurodesis was analyzed in patients with recurrent pleural effusion from breast carcinoma...
  63. ncbi request reprint Assessing the status of axillary sentinel lymph nodes of breast carcinoma patients by a real-time quantitative RT-PCR assay for mammaglobin 1 mRNA
    Patrizia Dell'Orto
    Department of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy
    Breast Cancer Res Treat 98:185-90. 2006
    ....
  64. ncbi request reprint Clinical utility of 99mTc-Sestamibi scintimammography in the management of equivocal breast lesions
    Concetta De Cicco
    Division of Nuclear Medicine, European Institute of Oncology, Milan, Italy
    Cancer Biother Radiopharm 19:621-6. 2004
    ..However, its use in nonpalpable tumors is not recommended...
  65. ncbi request reprint Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancer
    Mattia Intra
    Breast Division, University of Milan, Italy
    Arch Surg 137:737-40. 2002
    ..In our experience, IORT for limited-stage breast carcinoma is easy to perform and only briefly prolongs the duration of the surgical procedure...
  66. ncbi request reprint Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial
    Andrea Decensi
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Cancer Prev Res (Phila) 4:1181-9. 2011
    ....
  67. ncbi request reprint Breastfeeding in breast cancer survivors: pattern, behaviour and effect on breast cancer outcome
    Hatem A Azim
    Department of Medicine, Division of Haematology Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
    Breast 19:527-31. 2010
    ..Proper fertility and survivorship counselling is crucial and requires more attention in breast cancer clinics...
  68. doi request reprint NUMB controls p53 tumour suppressor activity
    Ivan N Colaluca
    IFOM, the FIRC Institute for Molecular Oncology Foundation, Via Adamello 16, 20139, Milan, Italy
    Nature 451:76-80. 2008
    ..Biologically, this results in an aggressive tumour phenotype, as witnessed by findings that NUMB-defective breast tumours display poor prognosis. Our results uncover a previously unknown tumour suppressor circuitry...